US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist

59.100
+1.590+2.76%

Close Nov 26 16:00 ET

61.500
+2.400+4.06%

Pre 04:14 ET

3.37BMarket Cap5.07P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-36.62%-84.22M

-8.75%-72.59M

-4.92%-99.87M

4.34%-296.06M

-9.56%-72.49M

13.61%-61.64M

10.08%-66.75M

2.61%-95.18M

1.47%-309.48M

17.29%-66.16M

Net income from continuing operations

1,137.97%947.92M

-14.69%-96.12M

-0.66%-81.55M

-51.89%-352.09M

-362.66%-95.94M

-11.72%-91.32M

8.71%-83.81M

14.51%-81.02M

34.98%-231.8M

137.05%36.53M

Operating gains losses

-50,103.75%-200.02M

---1K

-27.33%-191K

1,193.75%525K

457.14%275K

2,005.26%400K

--0

---150K

-500.00%-48K

-2,666.67%-77K

Depreciation and amortization

-17.13%1.35M

-11.84%1.59M

-24.69%1.35M

-22.66%6.62M

-22.66%1.4M

-18.07%1.62M

-21.13%1.81M

-27.76%1.79M

-7.32%8.56M

-17.62%1.81M

Other non cash items

-4,486.39%-886.23M

7.57%2.86M

7.48%2.8M

123.94%28.22M

102.20%2.75M

703.98%20.2M

6.93%2.66M

7.06%2.61M

-1,335.80%-117.86M

-5,303.07%-125.29M

Change In working capital

1,778.50%45.35M

164.98%10.13M

-12.45%-28.99M

-15.97%-19.06M

-50.52%5.6M

41.41%-2.7M

173.71%3.82M

-5.06%-25.78M

55.37%-16.43M

1,437.77%11.32M

-Change in receivables

-40.09%644K

34.67%-309K

-250.23%-643K

65.66%-604K

-199.82%-1.63M

183.33%1.08M

-129.51%-473K

128.03%428K

59.82%-1.76M

-120.87%-545K

-Change in inventory

-55.46%-2.49M

79.82%-867K

-38.58%-3.99M

-24.63%-10.58M

45.66%-1.8M

-43.64%-1.6M

-172.83%-4.3M

-15.98%-2.88M

---8.49M

---3.32M

-Change in prepaid assets

-221.65%-5.35M

86.74%4.58M

-1,075.57%-4.09M

2,277.84%3.83M

-54.63%3.39M

59.43%-1.66M

1,585.45%2.45M

89.74%-348K

99.34%-176K

198.45%7.48M

-Change in payables and accrued expense

1,818.15%56.34M

7.86%10.45M

6.10%-16.61M

124.52%4.08M

5.62%9.15M

-26.35%2.94M

51.39%9.69M

-2.67%-17.69M

-5.70%1.82M

9.14%8.66M

-Change in other current liabilities

-9.80%-3.79M

-5.02%-3.73M

30.98%-3.65M

-101.74%-15.79M

-265.55%-3.5M

-64.58%-3.45M

-49.94%-3.55M

-119.83%-5.29M

-3.96%-7.83M

56.69%-958K

Cash from discontinued investing activities

Operating cash flow

-36.62%-84.22M

-8.75%-72.59M

-4.92%-99.87M

4.34%-296.06M

-9.56%-72.49M

13.61%-61.64M

10.08%-66.75M

2.61%-95.18M

24.02%-309.48M

21.32%-66.16M

Investing cash flow

Cash flow from continuing investing activities

537.49%250.79M

-20.97%37.24M

116.27%124.56M

-1.52%239.58M

15.14%95.51M

-62.20%39.34M

-43.09%47.13M

316.75%57.6M

143.90%243.26M

187.85%82.95M

Net PPE purchase and sale

-151.99%-419K

-5,366.67%-158K

59.44%-101K

108.32%326K

-127.50%-234K

2,221.05%806K

100.16%3K

91.12%-249K

31.77%-3.92M

118.90%851K

Net intangibles purchase and sale

----

---17.5M

--0

----

--0

Net business purchase and sale

----

--0

----

--131.78M

----

Net investment purchase and sale

-1,595.36%-837.92M

-20.63%37.4M

115.51%124.66M

122.50%256.75M

292.71%95.75M

-46.18%56.04M

-44.39%47.12M

343.36%57.85M

121.04%115.39M

44.74%-49.68M

Cash from discontinued investing activities

Investing cash flow

537.49%250.79M

-20.97%37.24M

116.27%124.56M

-1.52%239.58M

15.14%95.51M

-62.20%39.34M

-43.09%47.13M

316.75%57.6M

-80.52%243.26M

187.85%82.95M

Financing cash flow

Cash flow from continuing financing activities

40.12%2.64M

363.71%1.1M

137.70%5.86M

131.19%5.43M

3,750.00%847K

58.55%1.88M

453.73%237K

104.22%2.47M

100.31%2.35M

100.12%22K

Net issuance payments of debt

----

--0

----

42.73%-331K

-142.56%-83K

Net common stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

40.12%2.64M

363.71%1.1M

137.70%5.86M

102.65%5.43M

706.67%847K

48.07%1.88M

1,381.25%237K

91.39%2.47M

-92.81%2.68M

-60.67%105K

Cash from discontinued financing activities

Financing cash flow

40.12%2.64M

363.71%1.1M

137.70%5.86M

131.19%5.43M

3,750.00%847K

58.55%1.88M

453.73%237K

104.22%2.47M

100.31%2.35M

100.12%22K

Net cash flow

Beginning cash position

-0.28%84.52M

14.04%118.76M

-36.66%88.21M

-31.44%139.26M

-47.46%64.33M

-4.28%84.75M

30.13%104.14M

-31.44%139.26M

59.39%203.13M

-69.40%122.45M

Current changes in cash

928.66%169.21M

-76.65%-34.25M

187.01%30.56M

20.06%-51.05M

42.01%23.87M

-160.23%-20.42M

-327.62%-19.39M

71.47%-35.12M

-184.38%-63.87M

108.53%16.81M

End cash Position

294.40%253.73M

-0.28%84.52M

14.04%118.76M

-36.66%88.21M

-47.46%64.33M

-4.28%84.75M

30.13%104.14M

-31.44%139.26M

Free cash flow

-6.45%-84.64M

-8.99%-72.75M

-4.63%-100.01M

-0.06%-314.56M

-9.73%-72.72M

-11.38%-79.51M

12.36%-66.75M

4.93%-95.58M

23.90%-314.36M

25.19%-66.28M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-36.62%-84.22M	-8.75%-72.59M	-4.92%-99.87M	4.34%-296.06M	-9.56%-72.49M	13.61%-61.64M	10.08%-66.75M	2.61%-95.18M	1.47%-309.48M	17.29%-66.16M
Net income from continuing operations	1,137.97%947.92M	-14.69%-96.12M	-0.66%-81.55M	-51.89%-352.09M	-362.66%-95.94M	-11.72%-91.32M	8.71%-83.81M	14.51%-81.02M	34.98%-231.8M	137.05%36.53M
Operating gains losses	-50,103.75%-200.02M	---1K	-27.33%-191K	1,193.75%525K	457.14%275K	2,005.26%400K	--0	---150K	-500.00%-48K	-2,666.67%-77K
Depreciation and amortization	-17.13%1.35M	-11.84%1.59M	-24.69%1.35M	-22.66%6.62M	-22.66%1.4M	-18.07%1.62M	-21.13%1.81M	-27.76%1.79M	-7.32%8.56M	-17.62%1.81M
Other non cash items	-4,486.39%-886.23M	7.57%2.86M	7.48%2.8M	123.94%28.22M	102.20%2.75M	703.98%20.2M	6.93%2.66M	7.06%2.61M	-1,335.80%-117.86M	-5,303.07%-125.29M
Change In working capital	1,778.50%45.35M	164.98%10.13M	-12.45%-28.99M	-15.97%-19.06M	-50.52%5.6M	41.41%-2.7M	173.71%3.82M	-5.06%-25.78M	55.37%-16.43M	1,437.77%11.32M
-Change in receivables	-40.09%644K	34.67%-309K	-250.23%-643K	65.66%-604K	-199.82%-1.63M	183.33%1.08M	-129.51%-473K	128.03%428K	59.82%-1.76M	-120.87%-545K
-Change in inventory	-55.46%-2.49M	79.82%-867K	-38.58%-3.99M	-24.63%-10.58M	45.66%-1.8M	-43.64%-1.6M	-172.83%-4.3M	-15.98%-2.88M	---8.49M	---3.32M
-Change in prepaid assets	-221.65%-5.35M	86.74%4.58M	-1,075.57%-4.09M	2,277.84%3.83M	-54.63%3.39M	59.43%-1.66M	1,585.45%2.45M	89.74%-348K	99.34%-176K	198.45%7.48M
-Change in payables and accrued expense	1,818.15%56.34M	7.86%10.45M	6.10%-16.61M	124.52%4.08M	5.62%9.15M	-26.35%2.94M	51.39%9.69M	-2.67%-17.69M	-5.70%1.82M	9.14%8.66M
-Change in other current liabilities	-9.80%-3.79M	-5.02%-3.73M	30.98%-3.65M	-101.74%-15.79M	-265.55%-3.5M	-64.58%-3.45M	-49.94%-3.55M	-119.83%-5.29M	-3.96%-7.83M	56.69%-958K
Cash from discontinued investing activities				0					0
Operating cash flow	-36.62%-84.22M	-8.75%-72.59M	-4.92%-99.87M	4.34%-296.06M	-9.56%-72.49M	13.61%-61.64M	10.08%-66.75M	2.61%-95.18M	24.02%-309.48M	21.32%-66.16M
Investing cash flow
Cash flow from continuing investing activities	537.49%250.79M	-20.97%37.24M	116.27%124.56M	-1.52%239.58M	15.14%95.51M	-62.20%39.34M	-43.09%47.13M	316.75%57.6M	143.90%243.26M	187.85%82.95M
Net PPE purchase and sale	-151.99%-419K	-5,366.67%-158K	59.44%-101K	108.32%326K	-127.50%-234K	2,221.05%806K	100.16%3K	91.12%-249K	31.77%-3.92M	118.90%851K
Net intangibles purchase and sale	----	----	----	---17.5M	--0	----	----	----	--0	--0
Net business purchase and sale	----	----	----	--0	--0	----	----	----	--131.78M	----
Net investment purchase and sale	-1,595.36%-837.92M	-20.63%37.4M	115.51%124.66M	122.50%256.75M	292.71%95.75M	-46.18%56.04M	-44.39%47.12M	343.36%57.85M	121.04%115.39M	44.74%-49.68M
Cash from discontinued investing activities
Investing cash flow	537.49%250.79M	-20.97%37.24M	116.27%124.56M	-1.52%239.58M	15.14%95.51M	-62.20%39.34M	-43.09%47.13M	316.75%57.6M	-80.52%243.26M	187.85%82.95M
Financing cash flow
Cash flow from continuing financing activities	40.12%2.64M	363.71%1.1M	137.70%5.86M	131.19%5.43M	3,750.00%847K	58.55%1.88M	453.73%237K	104.22%2.47M	100.31%2.35M	100.12%22K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	42.73%-331K	-142.56%-83K
Net common stock issuance	----	----	----	--0	----	----	----	----	--0	----
Proceeds from stock option exercised by employees	40.12%2.64M	363.71%1.1M	137.70%5.86M	102.65%5.43M	706.67%847K	48.07%1.88M	1,381.25%237K	91.39%2.47M	-92.81%2.68M	-60.67%105K
Cash from discontinued financing activities
Financing cash flow	40.12%2.64M	363.71%1.1M	137.70%5.86M	131.19%5.43M	3,750.00%847K	58.55%1.88M	453.73%237K	104.22%2.47M	100.31%2.35M	100.12%22K
Net cash flow
Beginning cash position	-0.28%84.52M	14.04%118.76M	-36.66%88.21M	-31.44%139.26M	-47.46%64.33M	-4.28%84.75M	30.13%104.14M	-31.44%139.26M	59.39%203.13M	-69.40%122.45M
Current changes in cash	928.66%169.21M	-76.65%-34.25M	187.01%30.56M	20.06%-51.05M	42.01%23.87M	-160.23%-20.42M	-327.62%-19.39M	71.47%-35.12M	-184.38%-63.87M	108.53%16.81M
End cash Position	294.40%253.73M	-0.28%84.52M	14.04%118.76M	-36.66%88.21M	-36.66%88.21M	-47.46%64.33M	-4.28%84.75M	30.13%104.14M	-31.44%139.26M	-31.44%139.26M
Free cash flow	-6.45%-84.64M	-8.99%-72.75M	-4.63%-100.01M	-0.06%-314.56M	-9.73%-72.72M	-11.38%-79.51M	12.36%-66.75M	4.93%-95.58M	23.90%-314.36M	25.19%-66.28M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data